ACOG 2026: James A. Simon, MD, discusses off-label evidence for elinzanetant in breast cancer survivors on anti-estrogenic therapy.
James A. Simon, MD
Advertisement
James A. Simon, MD, is the medical director and founder of IntimMedicine Specialists in Washington, DC.
Articles by James A. Simon, MD
ACOG 2026: James A. Simon, MD, discusses what the results mean for frontline clinician confidence in prescribing the non-hormonal VMS treatment.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Issues CRL to Cytisinicline for Smoking Cessation
2
Home Sleep Testing for GLP-1 Coverage Shows Modest Diagnostic Yield in New Study
3
Once-Nightly Oxybate in Narcolepsy: Real-World Outcomes Primary Care Should Know
4